HSAnnWebCardio-Getting to the Heart of It: Updates in Cardiology

Question Title

* 1. This activity met my educational needs.

Question Title

* 2. This activity increased my understanding in this area.

Question Title

* 3. The learning objectives were achieved

Question Title

* 4. The topic was relevant to my practice.

Question Title

* 5. The activity format was conducive to learning.

Question Title

* 6. This activity included effective learning assessment activities

Question Title

* 7. Learning assessment activities were appropriate.

Question Title

* 8. The activity was free from bias and commercial promotion.

Question Title

* 9. The content was current.

Question Title

* 10. The information provided will be useful in my practice.

Question Title

* 11. Educational materials were useful.

Question Title

* 12. Faculty was knowledgeable of the subject matter.

Question Title

* 13. Faculty's communication and presentation skills were of good quality.

Question Title

* 14. After participating in this activity, what is your current level of knowledge on this topic?

Question Title

* 15. What do you feel your level of knowledge/skill on this topic should be?

Question Title

* 16. Did this activity meet the following learning objective: Discuss clinical trial outcomes for angiotensin receptor antagonist/neprilysin inhibitor (ARNI) and sodiumglucose co-transporter 2 (SGLT2) inhibitors in heart failure and high-risk cardiac patients.

Question Title

* 17. Did this activity meet the following learning objective: Effectively utilize ARNI and SGLT2 inhibitors in various case scenarios based on patient specific
characteristics.

Question Title

* 18. Did this activity meet the following learning objective: Explain the role of three pathophysiological pathways in pulmonary arterial hypertension (PAH) and the respective medications which target these pathways.

Question Title

* 19. Did this activity meet the following learning objective: Develop an effective pharmacotherapy plan for a patient with PAH based on patient specific characteristics.

Question Title

* 20. Did this activity meet the following learning objective: Discuss clinical trial data that influenced development of the newest hypertension and hyperlipidemia guidelines.

Question Title

* 21. Did this activity meet the following learning objective: Identify new and emerging therapies in the treatment of hyperlipidemia.

Question Title

* 22. Month and day of birth

Question Title

* 23. EProfile Number

Question Title

* 24. I certify that I have completed this activity (please type your name)

Question Title

* 25. Please enter your email address

Question Title

* 26. Future programming suggestions

Question Title

* 27. What changes to her medication regimen would you recommend?

Question Title

* 28. Which medication below is FDA-approved to reduce risk of cardiovasular death and heart failure hospitalization in patients with heart failure with reduced ejection fraction with or without diabetes?

Question Title

* 29. Which of the following PAH medications would have a dangerous drug interaction with his new prescription?

Question Title

* 30. What BP goal do you tell your patient?

Question Title

* 31. Which of the following classes of medications have evidence for decreasing mortality? (Select all that apply)

T